Group 1 - The core stock of Zhonghui Biotech surged over 12% to HKD 37.5 after its initial public offering (IPO), which saw a remarkable increase of 158% on the first day of trading [2][3] - The stock opened at HKD 34.0, with a trading volume of 775,600 shares and a total transaction value of approximately HKD 27.72 million [3] - The company's total market capitalization reached HKD 14.754 billion, with a total share count of 393 million [3] Group 2 - Zhonghui Biotech issued a total of 33.4426 million H-shares at an offering price of HKD 12.90, which was at the lower end of the pricing range, raising approximately HKD 431 million [4] - The funds raised from the IPO will primarily be used for the development and registration of its core products, as well as for the development and registration of other vaccines in the pipeline, and to enhance its manufacturing processes and commercialization capabilities [4]
中慧生物盘初拉升涨超12%，昨日上市飙升158%！全球发行3344.26万股H股，最终发售价为12.90港元